Related Experiment Video
Updated: Sep 8, 2025

In Vivo, Percutaneous, Needle Based, Optical Coherence Tomography of Renal Masses
Published on: March 30, 2015
Evaluation of renal masses with CEST MRI: Protocol optimization and preliminary results
Xiaojing Wang1, Jochen Keupp2, Ivan E Dimitrov3,4
1Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Purpose:
This study investigates the application of CEST MRI in human kidneys, with the overarching goal of developing CEST MRI for renal mass characterization. Here, the focus is on the development of a protocol and the proof-of-principle evaluation of CEST for the characterization of clear cell renal cell carcinoma (ccRCC).
Methods:
Ten healthy volunteers and five patients diagnosed with ccRCC underwent CEST MRI scans at 3 T. The sequence performance was characterized in healthy volunteers and tested using three saturation power levels, B1rms = 0.7, 1.2, and 1.6 μT. We compared the magnetization transfer ratio asymmetry (MTRasym) values at 1.0, 2.0, and 3.5 ppm between the kidney cortex of healthy volunteers and the cortex/renal masses of renal cell carcinoma (RCC) patients. We also investigated the correlation of CEST with tumor characteristics, such as volume, necrosis percentage, and histopathological grade.
Results:
Significant differences in MTRasym values were observed between ccRCC tumor regions and healthy kidney cortex in all three compared frequency offset ranges (p < 0.05). At the same time, MTRasym values in the cortex of the contralateral kidney in RCC patients were not significantly different when compared with the values of healthy kidney cortex values (p > 0.7).
Conclusion:
CEST MRI demonstrates considerable potential as a non-invasive imaging tool for the characterization of renal masses.
Insights
Chemical Exchange Saturation Transfer (CEST) MRI shows promise for non-invasively characterizing renal masses. This technique can differentiate clear cell renal cell carcinoma (ccRCC) from healthy kidney tissue.
Area of Science:
- Magnetic Resonance Imaging
- Biomedical Engineering
- Oncology
Background:
- Renal mass characterization is crucial for diagnosis and treatment planning.
- Current imaging techniques have limitations in differentiating benign from malignant renal masses.
- Chemical Exchange Saturation Transfer (CEST) MRI is an emerging technique with potential for tissue characterization.
Purpose of the Study:
- To develop and evaluate a CEST MRI protocol for human kidney imaging.
- To assess the feasibility of using CEST MRI for characterizing clear cell renal cell carcinoma (ccRCC).
- To investigate the diagnostic potential of CEST MRI in distinguishing ccRCC from healthy renal tissue.
Main Methods:
- CEST MRI scans were performed at 3 Tesla on 10 healthy volunteers and 5 patients with ccRCC.
- Magnetization Transfer Ratio Asymmetry (MTRasym) values were compared between ccRCC tumors and healthy kidney cortex across different frequency offsets.
- Correlation between CEST parameters and tumor characteristics (volume, necrosis, grade) was analyzed.
Main Results:
- Significant differences in MTRasym values were observed between ccRCC tumors and healthy kidney cortex (p < 0.05).
- No significant differences in MTRasym values were found in the contralateral kidney cortex of RCC patients compared to healthy controls (p > 0.7).
- CEST MRI shows potential for differentiating ccRCC from normal kidney parenchyma.
Conclusions:
- CEST MRI is a promising non-invasive imaging tool for renal mass characterization.
- The developed protocol enables differentiation of ccRCC from healthy kidney tissue.
- Further research is warranted to explore the full clinical utility of CEST MRI in nephro-oncology.
Related Concept Videos
Imaging Studies IV: Magnetic Resonance Imaging
Imaging Studies I: Kidney, Ureter, and Bladder Studies
Imaging Studies III: Computed Tomography
Magnetic Resonance Imaging
Imaging Studies VII: Vascular Imaging

